English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [963]
News [2781]
Articles [132]
Editorials [3]
Conferences [92]
elearning [27]
Small cell lung cancer: Current standards of care
Dr Marianne Nicolson - Aberdeen Royal Infirmary, Aberdeen, UK
Small cell lung cancer: Current standards of care ( Dr Marianne Nicolson - Aberdeen Royal Infirmary, Aberdeen, UK )
26 Apr 2026
Maintenance in NSCLC: Q & A
Dr Besse and Dr Bhosle
Maintenance in NSCLC: Q & A ( Dr Besse and Dr Bhosle )
26 Apr 2026
Maintenance in NSCLC: Arguments for
Dr Jaishree Bhosle - The Royal Marsden NHS Foundation Trust, London, UK
Maintenance in NSCLC: Arguments for ( Dr Jaishree Bhosle - The Royal Marsden NHS Foundation Trust, London, UK )
26 Apr 2026
Maintenance in NSCLC: Arguments against
Dr Benjamin Besse - Institut Gustave Roussy, Paris, France
Maintenance in NSCLC: Arguments against ( Dr Benjamin Besse - Institut Gustave Roussy, Paris, France )
26 Apr 2026
We should use PDL1 and other biomarkers for selecting patients for immune...
Dr Mary O’Brien - The Royal Marsden NHS Foundation Trust, London, UK
We should use PDL1 and other biomarkers for selecting patients for immune checkpoint therapies ( Dr Mary O’Brien - The Royal Marsden NHS Foundation Trust, London, UK )
26 Apr 2026
We should not use PDL1 and other biomarkers for selecting patients for immune...
Prof Gordon McVie - King's College London, London, UK
We should not use PDL1 and other biomarkers for selecting patients for immune checkpoint therapies ( Prof Gordon McVie - King's College London, London, UK )
26 Apr 2026
Using PDL1 and other biomarkers in patient selection for immunology: Q & A
Dr O'Brien and Prof McVie
Using PDL1 and other biomarkers in patient selection for immunology: Q & A ( Dr O'Brien and Prof McVie )
26 Apr 2026
Current standards of care in advanced NSCLC
Dr Frances Shepherd - The Princess Margaret Cancer Centre, Toronto, Canada
Current standards of care in advanced NSCLC ( Dr Frances Shepherd - The Princess Margaret Cancer Centre, Toronto, Canada )
26 Apr 2026
Imaging and novel PET tracers: Q & A
Dr Giulia Veronesi and Prof Tony Ng
Imaging and novel PET tracers: Q & A ( Dr Giulia Veronesi and Prof Tony Ng )
26 Apr 2026
Imaging and novel PET tracers: The future
Prof Tony Ng - King's College London, London, UK
Imaging and novel PET tracers: The future ( Prof Tony Ng - King's College London, London, UK )
26 Apr 2026
Imaging and novel PET tracers: State of the art
Dr Giulia Veronesi - Humanitas Research Hospital, Milan, Italy
Imaging and novel PET tracers: State of the art ( Dr Giulia Veronesi - Humanitas Research Hospital, Milan, Italy )
26 Apr 2026
Radiotherapy - what's new? Q & A
Dr David Landau and Prof Corinne Favire-Finn
Radiotherapy - what's new? Q & A ( Dr David Landau and Prof Corinne Favire-Finn )
26 Apr 2026
<1…5152535455…81>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2026 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top